There's still a role for chemotherapy in the age of personalized medicine, NPR reports.

"We're in a transition state right now where the types of available treatments are changing," Robert Comis, an oncologist at Drexel University, says. "But we can't lose sight of the fact that cytotoxic chemotherapy has cured many, many patients."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.